Traws Pharma
TRAW
TRAW
29 hedge funds and large institutions have $1.29M invested in Traws Pharma in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
29
Holders Change
+4
Holders Change %
+16%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
O
1
OrbiMed
New York
|
$467K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$44.1K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$54.1K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$100K |
5 |
VF
5
Virtu Financial
New York
|
$12K |